PMV Pharmaceuticals, Inc.

Healthcare

NASDAQ:PMVP · NASDAQ Global Select

Market Cap $60.26M Beta 1.36 P/E (TTM) -0.8

$1.13 +3.91%

+$0.04 today

52W Low $0.96High $1.88

Vol 0.20M · Avg 0.38M

EPS (TTM) -$1.47Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+3.67%

Period High

$1.80

Period Low

$1.02

Latest

$1.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$487.30M

Immunic, Inc.

NASDAQ:IMUX

$140.13M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Repare Therapeutics Inc.

RPTX

$114.24M

Biomea Fusion, Inc.

NASDAQ:BMEA

$69.58M

Cibus, Inc.

NASDAQ:CBUS

$60.50M

TScan Therapeutics, Inc.

NASDAQ:TCRX

$56.04M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$48.91M

aTyr Pharma, Inc.

ATYR

$45.00M

Lite Strategy, Inc.

LITS

$29.14M

What is the latest PMVP filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does PMVP have?

Intrinsic Alpha currently shows 20 recent filings for PMVP.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.